nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRD1—epilepsy syndrome	0.353	0.567	CbGaD
Remifentanil—OPRM1—epilepsy syndrome	0.27	0.434	CbGaD
Remifentanil—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00531	0.143	CbGeAlD
Remifentanil—OPRD1—ganglion—epilepsy syndrome	0.00484	0.13	CbGeAlD
Remifentanil—OPRM1—ganglion—epilepsy syndrome	0.0033	0.0887	CbGeAlD
Remifentanil—OPRD1—forebrain—epilepsy syndrome	0.00203	0.0546	CbGeAlD
Remifentanil—OPRK1—forebrain—epilepsy syndrome	0.00195	0.0523	CbGeAlD
Remifentanil—OPRD1—telencephalon—epilepsy syndrome	0.00187	0.0502	CbGeAlD
Remifentanil—OPRM1—brainstem—epilepsy syndrome	0.00144	0.0386	CbGeAlD
Remifentanil—OPRM1—forebrain—epilepsy syndrome	0.00139	0.0372	CbGeAlD
Remifentanil—OPRM1—telencephalon—epilepsy syndrome	0.00127	0.0342	CbGeAlD
Remifentanil—OPRD1—head—epilepsy syndrome	0.00116	0.0313	CbGeAlD
Remifentanil—OPRK1—head—epilepsy syndrome	0.00112	0.03	CbGeAlD
Remifentanil—OPRD1—nervous system—epilepsy syndrome	0.0011	0.0296	CbGeAlD
Remifentanil—OPRD1—central nervous system—epilepsy syndrome	0.00106	0.0285	CbGeAlD
Remifentanil—OPRK1—nervous system—epilepsy syndrome	0.00106	0.0284	CbGeAlD
Remifentanil—OPRK1—central nervous system—epilepsy syndrome	0.00102	0.0274	CbGeAlD
Remifentanil—OPRK1—cerebellum—epilepsy syndrome	0.000995	0.0267	CbGeAlD
Remifentanil—OPRM1—midbrain—epilepsy syndrome	0.000915	0.0246	CbGeAlD
Remifentanil—OPRM1—spinal cord—epilepsy syndrome	0.000893	0.024	CbGeAlD
Remifentanil—Sufentanil—OPRD1—epilepsy syndrome	0.000856	0.157	CrCbGaD
Remifentanil—OPRD1—brain—epilepsy syndrome	0.000843	0.0227	CbGeAlD
Remifentanil—OPRK1—brain—epilepsy syndrome	0.000808	0.0217	CbGeAlD
Remifentanil—OPRM1—head—epilepsy syndrome	0.000793	0.0213	CbGeAlD
Remifentanil—OPRM1—nervous system—epilepsy syndrome	0.000752	0.0202	CbGeAlD
Remifentanil—OPRM1—central nervous system—epilepsy syndrome	0.000724	0.0195	CbGeAlD
Remifentanil—Anileridine—OPRM1—epilepsy syndrome	0.000717	0.132	CrCbGaD
Remifentanil—Sufentanil—OPRM1—epilepsy syndrome	0.000655	0.12	CrCbGaD
Remifentanil—Alfentanil—OPRM1—epilepsy syndrome	0.000609	0.112	CrCbGaD
Remifentanil—OPRM1—brain—epilepsy syndrome	0.000575	0.0154	CbGeAlD
Remifentanil—Pethidine—GRIN2A—epilepsy syndrome	0.000504	0.0925	CrCbGaD
Remifentanil—Pethidine—GRIN2B—epilepsy syndrome	0.000428	0.0787	CrCbGaD
Remifentanil—Fentanyl—OPRD1—epilepsy syndrome	0.000291	0.0535	CrCbGaD
Remifentanil—Pethidine—OPRM1—epilepsy syndrome	0.000275	0.0504	CrCbGaD
Remifentanil—Fentanyl—OPRM1—epilepsy syndrome	0.000223	0.041	CrCbGaD
Remifentanil—Alfentanil—ALB—epilepsy syndrome	0.000177	0.0324	CrCbGaD
Remifentanil—Alfentanil—ABCB1—epilepsy syndrome	0.000168	0.0309	CrCbGaD
Remifentanil—Pethidine—SLC6A4—epilepsy syndrome	0.000151	0.0278	CrCbGaD
Remifentanil—Pethidine—CYP2C19—epilepsy syndrome	0.000143	0.0263	CrCbGaD
Remifentanil—Pethidine—CYP2D6—epilepsy syndrome	0.000106	0.0195	CrCbGaD
Remifentanil—Pethidine—ALB—epilepsy syndrome	7.96e-05	0.0146	CrCbGaD
Remifentanil—Vomiting—Levetiracetam—epilepsy syndrome	7.02e-05	0.000302	CcSEcCtD
Remifentanil—Headache—Midazolam—epilepsy syndrome	7.01e-05	0.000301	CcSEcCtD
Remifentanil—Pruritus—Felbamate—epilepsy syndrome	7.01e-05	0.000301	CcSEcCtD
Remifentanil—Body temperature increased—Carbamazepine—epilepsy syndrome	7e-05	0.000301	CcSEcCtD
Remifentanil—Diarrhoea—Diazepam—epilepsy syndrome	7e-05	0.000301	CcSEcCtD
Remifentanil—Rash—Levetiracetam—epilepsy syndrome	6.97e-05	0.000299	CcSEcCtD
Remifentanil—Anaemia—Pregabalin—epilepsy syndrome	6.97e-05	0.000299	CcSEcCtD
Remifentanil—Dermatitis—Levetiracetam—epilepsy syndrome	6.96e-05	0.000299	CcSEcCtD
Remifentanil—Dry mouth—Valproic Acid—epilepsy syndrome	6.94e-05	0.000298	CcSEcCtD
Remifentanil—Agitation—Pregabalin—epilepsy syndrome	6.93e-05	0.000297	CcSEcCtD
Remifentanil—Headache—Levetiracetam—epilepsy syndrome	6.92e-05	0.000297	CcSEcCtD
Remifentanil—Erythema—Gabapentin—epilepsy syndrome	6.91e-05	0.000297	CcSEcCtD
Remifentanil—Hypersensitivity—Clonazepam—epilepsy syndrome	6.88e-05	0.000295	CcSEcCtD
Remifentanil—Dizziness—Vigabatrin—epilepsy syndrome	6.87e-05	0.000295	CcSEcCtD
Remifentanil—Confusional state—Valproic Acid—epilepsy syndrome	6.86e-05	0.000294	CcSEcCtD
Remifentanil—Pruritus—Zonisamide—epilepsy syndrome	6.86e-05	0.000294	CcSEcCtD
Remifentanil—Hypersensitivity—Phenytoin—epilepsy syndrome	6.84e-05	0.000294	CcSEcCtD
Remifentanil—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.8e-05	0.000292	CcSEcCtD
Remifentanil—Oedema—Valproic Acid—epilepsy syndrome	6.8e-05	0.000292	CcSEcCtD
Remifentanil—Urticaria—Lamotrigine—epilepsy syndrome	6.8e-05	0.000292	CcSEcCtD
Remifentanil—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.8e-05	0.000292	CcSEcCtD
Remifentanil—Bradycardia—Topiramate—epilepsy syndrome	6.8e-05	0.000292	CcSEcCtD
Remifentanil—Nausea—Propofol—epilepsy syndrome	6.79e-05	0.000292	CcSEcCtD
Remifentanil—Vomiting—Fosphenytoin—epilepsy syndrome	6.78e-05	0.000291	CcSEcCtD
Remifentanil—Diarrhoea—Felbamate—epilepsy syndrome	6.78e-05	0.000291	CcSEcCtD
Remifentanil—Body temperature increased—Lamotrigine—epilepsy syndrome	6.77e-05	0.000291	CcSEcCtD
Remifentanil—Dizziness—Diazepam—epilepsy syndrome	6.77e-05	0.00029	CcSEcCtD
Remifentanil—Syncope—Pregabalin—epilepsy syndrome	6.76e-05	0.00029	CcSEcCtD
Remifentanil—Rash—Fosphenytoin—epilepsy syndrome	6.72e-05	0.000289	CcSEcCtD
Remifentanil—Dermatitis—Fosphenytoin—epilepsy syndrome	6.72e-05	0.000288	CcSEcCtD
Remifentanil—Haemoglobin—Topiramate—epilepsy syndrome	6.71e-05	0.000288	CcSEcCtD
Remifentanil—Headache—Fosphenytoin—epilepsy syndrome	6.68e-05	0.000287	CcSEcCtD
Remifentanil—Haemorrhage—Topiramate—epilepsy syndrome	6.68e-05	0.000287	CcSEcCtD
Remifentanil—Nervous system disorder—Valproic Acid—epilepsy syndrome	6.67e-05	0.000286	CcSEcCtD
Remifentanil—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.66e-05	0.000286	CcSEcCtD
Remifentanil—Nausea—Midazolam—epilepsy syndrome	6.65e-05	0.000285	CcSEcCtD
Remifentanil—Hallucination—Topiramate—epilepsy syndrome	6.65e-05	0.000285	CcSEcCtD
Remifentanil—Tachycardia—Valproic Acid—epilepsy syndrome	6.64e-05	0.000285	CcSEcCtD
Remifentanil—Diarrhoea—Zonisamide—epilepsy syndrome	6.63e-05	0.000285	CcSEcCtD
Remifentanil—Pharyngitis—Topiramate—epilepsy syndrome	6.63e-05	0.000285	CcSEcCtD
Remifentanil—Loss of consciousness—Pregabalin—epilepsy syndrome	6.62e-05	0.000284	CcSEcCtD
Remifentanil—Pruritus—Clonazepam—epilepsy syndrome	6.61e-05	0.000284	CcSEcCtD
Remifentanil—Vomiting—Vigabatrin—epilepsy syndrome	6.61e-05	0.000284	CcSEcCtD
Remifentanil—Skin disorder—Valproic Acid—epilepsy syndrome	6.61e-05	0.000284	CcSEcCtD
Remifentanil—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.58e-05	0.000282	CcSEcCtD
Remifentanil—Cough—Pregabalin—epilepsy syndrome	6.58e-05	0.000282	CcSEcCtD
Remifentanil—Pruritus—Phenytoin—epilepsy syndrome	6.57e-05	0.000282	CcSEcCtD
Remifentanil—Nausea—Levetiracetam—epilepsy syndrome	6.56e-05	0.000282	CcSEcCtD
Remifentanil—Rash—Vigabatrin—epilepsy syndrome	6.55e-05	0.000281	CcSEcCtD
Remifentanil—Dizziness—Felbamate—epilepsy syndrome	6.55e-05	0.000281	CcSEcCtD
Remifentanil—Dermatitis—Vigabatrin—epilepsy syndrome	6.55e-05	0.000281	CcSEcCtD
Remifentanil—Pruritus—Oxcarbazepine—epilepsy syndrome	6.53e-05	0.00028	CcSEcCtD
Remifentanil—Convulsion—Pregabalin—epilepsy syndrome	6.53e-05	0.00028	CcSEcCtD
Remifentanil—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.53e-05	0.00028	CcSEcCtD
Remifentanil—Headache—Vigabatrin—epilepsy syndrome	6.51e-05	0.00028	CcSEcCtD
Remifentanil—Hypertension—Pregabalin—epilepsy syndrome	6.51e-05	0.000279	CcSEcCtD
Remifentanil—Vomiting—Diazepam—epilepsy syndrome	6.51e-05	0.000279	CcSEcCtD
Remifentanil—Tremor—Gabapentin—epilepsy syndrome	6.47e-05	0.000278	CcSEcCtD
Remifentanil—Rash—Diazepam—epilepsy syndrome	6.45e-05	0.000277	CcSEcCtD
Remifentanil—Dermatitis—Diazepam—epilepsy syndrome	6.45e-05	0.000277	CcSEcCtD
Remifentanil—Visual impairment—Topiramate—epilepsy syndrome	6.44e-05	0.000276	CcSEcCtD
Remifentanil—Dizziness—Zonisamide—epilepsy syndrome	6.41e-05	0.000275	CcSEcCtD
Remifentanil—Headache—Diazepam—epilepsy syndrome	6.41e-05	0.000275	CcSEcCtD
Remifentanil—Anxiety—Pregabalin—epilepsy syndrome	6.39e-05	0.000274	CcSEcCtD
Remifentanil—Diarrhoea—Clonazepam—epilepsy syndrome	6.39e-05	0.000274	CcSEcCtD
Remifentanil—Anaemia—Gabapentin—epilepsy syndrome	6.39e-05	0.000274	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.37e-05	0.000274	CcSEcCtD
Remifentanil—Hypotension—Valproic Acid—epilepsy syndrome	6.36e-05	0.000273	CcSEcCtD
Remifentanil—Agitation—Gabapentin—epilepsy syndrome	6.35e-05	0.000273	CcSEcCtD
Remifentanil—Diarrhoea—Phenytoin—epilepsy syndrome	6.35e-05	0.000273	CcSEcCtD
Remifentanil—Nausea—Fosphenytoin—epilepsy syndrome	6.33e-05	0.000272	CcSEcCtD
Remifentanil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.32e-05	0.000271	CcSEcCtD
Remifentanil—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.31e-05	0.000271	CcSEcCtD
Remifentanil—Vomiting—Felbamate—epilepsy syndrome	6.3e-05	0.00027	CcSEcCtD
Remifentanil—Dry mouth—Pregabalin—epilepsy syndrome	6.27e-05	0.000269	CcSEcCtD
Remifentanil—Pruritus—Carbamazepine—epilepsy syndrome	6.27e-05	0.000269	CcSEcCtD
Remifentanil—Rash—Felbamate—epilepsy syndrome	6.24e-05	0.000268	CcSEcCtD
Remifentanil—Dermatitis—Felbamate—epilepsy syndrome	6.24e-05	0.000268	CcSEcCtD
Remifentanil—Headache—Felbamate—epilepsy syndrome	6.2e-05	0.000266	CcSEcCtD
Remifentanil—Confusional state—Pregabalin—epilepsy syndrome	6.2e-05	0.000266	CcSEcCtD
Remifentanil—Cardiac disorder—Topiramate—epilepsy syndrome	6.2e-05	0.000266	CcSEcCtD
Remifentanil—Flushing—Topiramate—epilepsy syndrome	6.2e-05	0.000266	CcSEcCtD
Remifentanil—Syncope—Gabapentin—epilepsy syndrome	6.2e-05	0.000266	CcSEcCtD
Remifentanil—Dizziness—Clonazepam—epilepsy syndrome	6.18e-05	0.000265	CcSEcCtD
Remifentanil—Nausea—Vigabatrin—epilepsy syndrome	6.17e-05	0.000265	CcSEcCtD
Remifentanil—Fentanyl—ABCB1—epilepsy syndrome	6.17e-05	0.0113	CrCbGaD
Remifentanil—Vomiting—Zonisamide—epilepsy syndrome	6.16e-05	0.000265	CcSEcCtD
Remifentanil—Oedema—Pregabalin—epilepsy syndrome	6.15e-05	0.000264	CcSEcCtD
Remifentanil—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.15e-05	0.000264	CcSEcCtD
Remifentanil—Dizziness—Phenytoin—epilepsy syndrome	6.14e-05	0.000263	CcSEcCtD
Remifentanil—Rash—Zonisamide—epilepsy syndrome	6.11e-05	0.000262	CcSEcCtD
Remifentanil—Paraesthesia—Valproic Acid—epilepsy syndrome	6.11e-05	0.000262	CcSEcCtD
Remifentanil—Dermatitis—Zonisamide—epilepsy syndrome	6.11e-05	0.000262	CcSEcCtD
Remifentanil—Dizziness—Oxcarbazepine—epilepsy syndrome	6.1e-05	0.000262	CcSEcCtD
Remifentanil—Nausea—Diazepam—epilepsy syndrome	6.08e-05	0.000261	CcSEcCtD
Remifentanil—Loss of consciousness—Gabapentin—epilepsy syndrome	6.07e-05	0.000261	CcSEcCtD
Remifentanil—Headache—Zonisamide—epilepsy syndrome	6.07e-05	0.000261	CcSEcCtD
Remifentanil—Dyspnoea—Valproic Acid—epilepsy syndrome	6.07e-05	0.00026	CcSEcCtD
Remifentanil—Diarrhoea—Carbamazepine—epilepsy syndrome	6.06e-05	0.00026	CcSEcCtD
Remifentanil—Angiopathy—Topiramate—epilepsy syndrome	6.06e-05	0.00026	CcSEcCtD
Remifentanil—Pruritus—Lamotrigine—epilepsy syndrome	6.06e-05	0.00026	CcSEcCtD
Remifentanil—Shock—Pregabalin—epilepsy syndrome	6.05e-05	0.00026	CcSEcCtD
Remifentanil—Somnolence—Valproic Acid—epilepsy syndrome	6.05e-05	0.00026	CcSEcCtD
Remifentanil—Immune system disorder—Topiramate—epilepsy syndrome	6.03e-05	0.000259	CcSEcCtD
Remifentanil—Nervous system disorder—Pregabalin—epilepsy syndrome	6.03e-05	0.000259	CcSEcCtD
Remifentanil—Cough—Gabapentin—epilepsy syndrome	6.03e-05	0.000259	CcSEcCtD
Remifentanil—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.02e-05	0.000259	CcSEcCtD
Remifentanil—Mediastinal disorder—Topiramate—epilepsy syndrome	6.02e-05	0.000258	CcSEcCtD
Remifentanil—Tachycardia—Pregabalin—epilepsy syndrome	6e-05	0.000258	CcSEcCtD
Remifentanil—Chills—Topiramate—epilepsy syndrome	5.99e-05	0.000257	CcSEcCtD
Remifentanil—Dyspepsia—Valproic Acid—epilepsy syndrome	5.99e-05	0.000257	CcSEcCtD
Remifentanil—Convulsion—Gabapentin—epilepsy syndrome	5.99e-05	0.000257	CcSEcCtD
Remifentanil—Skin disorder—Pregabalin—epilepsy syndrome	5.97e-05	0.000256	CcSEcCtD
Remifentanil—Hypertension—Gabapentin—epilepsy syndrome	5.97e-05	0.000256	CcSEcCtD
Remifentanil—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.95e-05	0.000255	CcSEcCtD
Remifentanil—Vomiting—Clonazepam—epilepsy syndrome	5.94e-05	0.000255	CcSEcCtD
Remifentanil—Vomiting—Phenytoin—epilepsy syndrome	5.9e-05	0.000253	CcSEcCtD
Remifentanil—Rash—Clonazepam—epilepsy syndrome	5.89e-05	0.000253	CcSEcCtD
Remifentanil—Dermatitis—Clonazepam—epilepsy syndrome	5.89e-05	0.000253	CcSEcCtD
Remifentanil—Nausea—Felbamate—epilepsy syndrome	5.88e-05	0.000253	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.87e-05	0.000252	CcSEcCtD
Remifentanil—Vomiting—Oxcarbazepine—epilepsy syndrome	5.87e-05	0.000252	CcSEcCtD
Remifentanil—Anxiety—Gabapentin—epilepsy syndrome	5.86e-05	0.000252	CcSEcCtD
Remifentanil—Dizziness—Carbamazepine—epilepsy syndrome	5.86e-05	0.000251	CcSEcCtD
Remifentanil—Diarrhoea—Lamotrigine—epilepsy syndrome	5.86e-05	0.000251	CcSEcCtD
Remifentanil—Headache—Clonazepam—epilepsy syndrome	5.85e-05	0.000251	CcSEcCtD
Remifentanil—Rash—Phenytoin—epilepsy syndrome	5.85e-05	0.000251	CcSEcCtD
Remifentanil—Dermatitis—Phenytoin—epilepsy syndrome	5.85e-05	0.000251	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.84e-05	0.000251	CcSEcCtD
Remifentanil—Rash—Oxcarbazepine—epilepsy syndrome	5.82e-05	0.00025	CcSEcCtD
Remifentanil—Pain—Valproic Acid—epilepsy syndrome	5.82e-05	0.00025	CcSEcCtD
Remifentanil—Constipation—Valproic Acid—epilepsy syndrome	5.82e-05	0.00025	CcSEcCtD
Remifentanil—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.82e-05	0.00025	CcSEcCtD
Remifentanil—Headache—Phenytoin—epilepsy syndrome	5.81e-05	0.00025	CcSEcCtD
Remifentanil—Erythema—Topiramate—epilepsy syndrome	5.81e-05	0.00025	CcSEcCtD
Remifentanil—Headache—Oxcarbazepine—epilepsy syndrome	5.78e-05	0.000248	CcSEcCtD
Remifentanil—Nausea—Zonisamide—epilepsy syndrome	5.76e-05	0.000247	CcSEcCtD
Remifentanil—Dry mouth—Gabapentin—epilepsy syndrome	5.75e-05	0.000247	CcSEcCtD
Remifentanil—Hypotension—Pregabalin—epilepsy syndrome	5.75e-05	0.000247	CcSEcCtD
Remifentanil—Confusional state—Gabapentin—epilepsy syndrome	5.69e-05	0.000244	CcSEcCtD
Remifentanil—Dizziness—Lamotrigine—epilepsy syndrome	5.66e-05	0.000243	CcSEcCtD
Remifentanil—Oedema—Gabapentin—epilepsy syndrome	5.64e-05	0.000242	CcSEcCtD
Remifentanil—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.64e-05	0.000242	CcSEcCtD
Remifentanil—Vomiting—Carbamazepine—epilepsy syndrome	5.63e-05	0.000242	CcSEcCtD
Remifentanil—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.61e-05	0.000241	CcSEcCtD
Remifentanil—Rash—Carbamazepine—epilepsy syndrome	5.59e-05	0.00024	CcSEcCtD
Remifentanil—Dermatitis—Carbamazepine—epilepsy syndrome	5.58e-05	0.00024	CcSEcCtD
Remifentanil—Nausea—Clonazepam—epilepsy syndrome	5.55e-05	0.000238	CcSEcCtD
Remifentanil—Headache—Carbamazepine—epilepsy syndrome	5.55e-05	0.000238	CcSEcCtD
Remifentanil—Shock—Gabapentin—epilepsy syndrome	5.55e-05	0.000238	CcSEcCtD
Remifentanil—Nervous system disorder—Gabapentin—epilepsy syndrome	5.53e-05	0.000237	CcSEcCtD
Remifentanil—Paraesthesia—Pregabalin—epilepsy syndrome	5.52e-05	0.000237	CcSEcCtD
Remifentanil—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.52e-05	0.000237	CcSEcCtD
Remifentanil—Nausea—Phenytoin—epilepsy syndrome	5.51e-05	0.000237	CcSEcCtD
Remifentanil—Tachycardia—Gabapentin—epilepsy syndrome	5.5e-05	0.000236	CcSEcCtD
Remifentanil—Dyspnoea—Pregabalin—epilepsy syndrome	5.48e-05	0.000235	CcSEcCtD
Remifentanil—Nausea—Oxcarbazepine—epilepsy syndrome	5.48e-05	0.000235	CcSEcCtD
Remifentanil—Skin disorder—Gabapentin—epilepsy syndrome	5.48e-05	0.000235	CcSEcCtD
Remifentanil—Somnolence—Pregabalin—epilepsy syndrome	5.47e-05	0.000235	CcSEcCtD
Remifentanil—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.45e-05	0.000234	CcSEcCtD
Remifentanil—Tremor—Topiramate—epilepsy syndrome	5.45e-05	0.000234	CcSEcCtD
Remifentanil—Vomiting—Lamotrigine—epilepsy syndrome	5.44e-05	0.000234	CcSEcCtD
Remifentanil—Urticaria—Valproic Acid—epilepsy syndrome	5.4e-05	0.000232	CcSEcCtD
Remifentanil—Rash—Lamotrigine—epilepsy syndrome	5.4e-05	0.000232	CcSEcCtD
Remifentanil—Dermatitis—Lamotrigine—epilepsy syndrome	5.39e-05	0.000232	CcSEcCtD
Remifentanil—Body temperature increased—Valproic Acid—epilepsy syndrome	5.38e-05	0.000231	CcSEcCtD
Remifentanil—Anaemia—Topiramate—epilepsy syndrome	5.37e-05	0.000231	CcSEcCtD
Remifentanil—Headache—Lamotrigine—epilepsy syndrome	5.36e-05	0.00023	CcSEcCtD
Remifentanil—Agitation—Topiramate—epilepsy syndrome	5.34e-05	0.000229	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.31e-05	0.000228	CcSEcCtD
Remifentanil—Hypotension—Gabapentin—epilepsy syndrome	5.27e-05	0.000226	CcSEcCtD
Remifentanil—Nausea—Carbamazepine—epilepsy syndrome	5.26e-05	0.000226	CcSEcCtD
Remifentanil—Pain—Pregabalin—epilepsy syndrome	5.26e-05	0.000226	CcSEcCtD
Remifentanil—Constipation—Pregabalin—epilepsy syndrome	5.26e-05	0.000226	CcSEcCtD
Remifentanil—Syncope—Topiramate—epilepsy syndrome	5.21e-05	0.000224	CcSEcCtD
Remifentanil—Loss of consciousness—Topiramate—epilepsy syndrome	5.11e-05	0.000219	CcSEcCtD
Remifentanil—Nausea—Lamotrigine—epilepsy syndrome	5.09e-05	0.000218	CcSEcCtD
Remifentanil—Cough—Topiramate—epilepsy syndrome	5.07e-05	0.000218	CcSEcCtD
Remifentanil—Feeling abnormal—Pregabalin—epilepsy syndrome	5.07e-05	0.000218	CcSEcCtD
Remifentanil—Paraesthesia—Gabapentin—epilepsy syndrome	5.06e-05	0.000217	CcSEcCtD
Remifentanil—Convulsion—Topiramate—epilepsy syndrome	5.04e-05	0.000216	CcSEcCtD
Remifentanil—Dyspnoea—Gabapentin—epilepsy syndrome	5.03e-05	0.000216	CcSEcCtD
Remifentanil—Hypertension—Topiramate—epilepsy syndrome	5.02e-05	0.000215	CcSEcCtD
Remifentanil—Somnolence—Gabapentin—epilepsy syndrome	5.01e-05	0.000215	CcSEcCtD
Remifentanil—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.01e-05	0.000215	CcSEcCtD
Remifentanil—Dyspepsia—Gabapentin—epilepsy syndrome	4.96e-05	0.000213	CcSEcCtD
Remifentanil—Anxiety—Topiramate—epilepsy syndrome	4.93e-05	0.000212	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.92e-05	0.000211	CcSEcCtD
Remifentanil—Urticaria—Pregabalin—epilepsy syndrome	4.89e-05	0.00021	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.87e-05	0.000209	CcSEcCtD
Remifentanil—Body temperature increased—Pregabalin—epilepsy syndrome	4.86e-05	0.000209	CcSEcCtD
Remifentanil—Dry mouth—Topiramate—epilepsy syndrome	4.84e-05	0.000208	CcSEcCtD
Remifentanil—Pain—Gabapentin—epilepsy syndrome	4.82e-05	0.000207	CcSEcCtD
Remifentanil—Constipation—Gabapentin—epilepsy syndrome	4.82e-05	0.000207	CcSEcCtD
Remifentanil—Pruritus—Valproic Acid—epilepsy syndrome	4.81e-05	0.000207	CcSEcCtD
Remifentanil—Confusional state—Topiramate—epilepsy syndrome	4.78e-05	0.000205	CcSEcCtD
Remifentanil—Oedema—Topiramate—epilepsy syndrome	4.75e-05	0.000204	CcSEcCtD
Remifentanil—Shock—Topiramate—epilepsy syndrome	4.67e-05	0.0002	CcSEcCtD
Remifentanil—Diarrhoea—Valproic Acid—epilepsy syndrome	4.65e-05	0.0002	CcSEcCtD
Remifentanil—Nervous system disorder—Topiramate—epilepsy syndrome	4.65e-05	0.0002	CcSEcCtD
Remifentanil—Feeling abnormal—Gabapentin—epilepsy syndrome	4.65e-05	0.0002	CcSEcCtD
Remifentanil—Thrombocytopenia—Topiramate—epilepsy syndrome	4.65e-05	0.000199	CcSEcCtD
Remifentanil—Tachycardia—Topiramate—epilepsy syndrome	4.63e-05	0.000199	CcSEcCtD
Remifentanil—Skin disorder—Topiramate—epilepsy syndrome	4.61e-05	0.000198	CcSEcCtD
Remifentanil—Hyperhidrosis—Topiramate—epilepsy syndrome	4.59e-05	0.000197	CcSEcCtD
Remifentanil—Hypersensitivity—Pregabalin—epilepsy syndrome	4.53e-05	0.000195	CcSEcCtD
Remifentanil—Dizziness—Valproic Acid—epilepsy syndrome	4.5e-05	0.000193	CcSEcCtD
Remifentanil—Urticaria—Gabapentin—epilepsy syndrome	4.48e-05	0.000192	CcSEcCtD
Remifentanil—Body temperature increased—Gabapentin—epilepsy syndrome	4.46e-05	0.000191	CcSEcCtD
Remifentanil—Hypotension—Topiramate—epilepsy syndrome	4.43e-05	0.00019	CcSEcCtD
Remifentanil—Pruritus—Pregabalin—epilepsy syndrome	4.35e-05	0.000187	CcSEcCtD
Remifentanil—Vomiting—Valproic Acid—epilepsy syndrome	4.33e-05	0.000186	CcSEcCtD
Remifentanil—Rash—Valproic Acid—epilepsy syndrome	4.29e-05	0.000184	CcSEcCtD
Remifentanil—Dermatitis—Valproic Acid—epilepsy syndrome	4.29e-05	0.000184	CcSEcCtD
Remifentanil—Headache—Valproic Acid—epilepsy syndrome	4.26e-05	0.000183	CcSEcCtD
Remifentanil—Paraesthesia—Topiramate—epilepsy syndrome	4.26e-05	0.000183	CcSEcCtD
Remifentanil—Dyspnoea—Topiramate—epilepsy syndrome	4.23e-05	0.000182	CcSEcCtD
Remifentanil—Somnolence—Topiramate—epilepsy syndrome	4.22e-05	0.000181	CcSEcCtD
Remifentanil—Diarrhoea—Pregabalin—epilepsy syndrome	4.21e-05	0.000181	CcSEcCtD
Remifentanil—Dyspepsia—Topiramate—epilepsy syndrome	4.18e-05	0.000179	CcSEcCtD
Remifentanil—Hypersensitivity—Gabapentin—epilepsy syndrome	4.16e-05	0.000178	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.1e-05	0.000176	CcSEcCtD
Remifentanil—Dizziness—Pregabalin—epilepsy syndrome	4.07e-05	0.000175	CcSEcCtD
Remifentanil—Constipation—Topiramate—epilepsy syndrome	4.06e-05	0.000174	CcSEcCtD
Remifentanil—Pain—Topiramate—epilepsy syndrome	4.06e-05	0.000174	CcSEcCtD
Remifentanil—Nausea—Valproic Acid—epilepsy syndrome	4.04e-05	0.000173	CcSEcCtD
Remifentanil—Pruritus—Gabapentin—epilepsy syndrome	3.99e-05	0.000171	CcSEcCtD
Remifentanil—Vomiting—Pregabalin—epilepsy syndrome	3.91e-05	0.000168	CcSEcCtD
Remifentanil—Feeling abnormal—Topiramate—epilepsy syndrome	3.91e-05	0.000168	CcSEcCtD
Remifentanil—Rash—Pregabalin—epilepsy syndrome	3.88e-05	0.000166	CcSEcCtD
Remifentanil—Dermatitis—Pregabalin—epilepsy syndrome	3.87e-05	0.000166	CcSEcCtD
Remifentanil—Diarrhoea—Gabapentin—epilepsy syndrome	3.86e-05	0.000166	CcSEcCtD
Remifentanil—Headache—Pregabalin—epilepsy syndrome	3.85e-05	0.000165	CcSEcCtD
Remifentanil—Urticaria—Topiramate—epilepsy syndrome	3.77e-05	0.000162	CcSEcCtD
Remifentanil—Body temperature increased—Topiramate—epilepsy syndrome	3.75e-05	0.000161	CcSEcCtD
Remifentanil—Dizziness—Gabapentin—epilepsy syndrome	3.73e-05	0.00016	CcSEcCtD
Remifentanil—Nausea—Pregabalin—epilepsy syndrome	3.65e-05	0.000157	CcSEcCtD
Remifentanil—Vomiting—Gabapentin—epilepsy syndrome	3.59e-05	0.000154	CcSEcCtD
Remifentanil—Rash—Gabapentin—epilepsy syndrome	3.56e-05	0.000153	CcSEcCtD
Remifentanil—Dermatitis—Gabapentin—epilepsy syndrome	3.55e-05	0.000153	CcSEcCtD
Remifentanil—Headache—Gabapentin—epilepsy syndrome	3.53e-05	0.000152	CcSEcCtD
Remifentanil—Hypersensitivity—Topiramate—epilepsy syndrome	3.5e-05	0.00015	CcSEcCtD
Remifentanil—Pruritus—Topiramate—epilepsy syndrome	3.36e-05	0.000144	CcSEcCtD
Remifentanil—Nausea—Gabapentin—epilepsy syndrome	3.35e-05	0.000144	CcSEcCtD
Remifentanil—Diarrhoea—Topiramate—epilepsy syndrome	3.25e-05	0.000139	CcSEcCtD
Remifentanil—Dizziness—Topiramate—epilepsy syndrome	3.14e-05	0.000135	CcSEcCtD
Remifentanil—Vomiting—Topiramate—epilepsy syndrome	3.02e-05	0.00013	CcSEcCtD
Remifentanil—Rash—Topiramate—epilepsy syndrome	2.99e-05	0.000128	CcSEcCtD
Remifentanil—Dermatitis—Topiramate—epilepsy syndrome	2.99e-05	0.000128	CcSEcCtD
Remifentanil—Headache—Topiramate—epilepsy syndrome	2.97e-05	0.000128	CcSEcCtD
Remifentanil—Nausea—Topiramate—epilepsy syndrome	2.82e-05	0.000121	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—SST—epilepsy syndrome	2.31e-05	0.000228	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR2—epilepsy syndrome	2.31e-05	0.000228	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—OPRM1—epilepsy syndrome	2.3e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	2.29e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AVP—epilepsy syndrome	2.28e-05	0.000225	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—POMC—epilepsy syndrome	2.27e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.26e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.24e-05	0.00022	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL2—epilepsy syndrome	2.22e-05	0.000219	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.22e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—OPRD1—epilepsy syndrome	2.21e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNAO1—epilepsy syndrome	2.21e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.19e-05	0.000216	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CHRM2—epilepsy syndrome	2.19e-05	0.000216	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.19e-05	0.000216	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	2.19e-05	0.000215	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.18e-05	0.000214	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	2.18e-05	0.000214	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR3—epilepsy syndrome	2.17e-05	0.000214	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.17e-05	0.000214	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CDC42—epilepsy syndrome	2.14e-05	0.000211	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CNR1—epilepsy syndrome	2.13e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GABBR1—epilepsy syndrome	2.13e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.13e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR7—epilepsy syndrome	2.12e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDYN—epilepsy syndrome	2.12e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CHRM1—epilepsy syndrome	2.12e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GRM1—epilepsy syndrome	2.12e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NPY—epilepsy syndrome	2.11e-05	0.000208	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.11e-05	0.000208	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR7—epilepsy syndrome	2.08e-05	0.000205	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AVP—epilepsy syndrome	2.07e-05	0.000204	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AGT—epilepsy syndrome	2.06e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HRH3—epilepsy syndrome	2.05e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HSPB1—epilepsy syndrome	2.04e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL2—epilepsy syndrome	2.04e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—OXT—epilepsy syndrome	2.04e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CRH—epilepsy syndrome	2.04e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL3—epilepsy syndrome	2.04e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.02e-05	0.000199	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—OPRM1—epilepsy syndrome	2.01e-05	0.000198	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR5—epilepsy syndrome	2.01e-05	0.000198	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.99e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GAL—epilepsy syndrome	1.99e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GFAP—epilepsy syndrome	1.99e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT3—epilepsy syndrome	1.98e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CHRM3—epilepsy syndrome	1.97e-05	0.000194	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP2—epilepsy syndrome	1.97e-05	0.000194	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GRM5—epilepsy syndrome	1.97e-05	0.000194	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.97e-05	0.000194	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.94e-05	0.000191	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AVP—epilepsy syndrome	1.93e-05	0.00019	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR3—epilepsy syndrome	1.9e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.9e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.9e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TSC1—epilepsy syndrome	1.9e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTK2B—epilepsy syndrome	1.9e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.89e-05	0.000186	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AGT—epilepsy syndrome	1.87e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.85e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.85e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.85e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NPY—epilepsy syndrome	1.85e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.85e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR2—epilepsy syndrome	1.84e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NTRK2—epilepsy syndrome	1.84e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SST—epilepsy syndrome	1.84e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DUSP6—epilepsy syndrome	1.83e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.81e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.8e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AGT—epilepsy syndrome	1.8e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.8e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLAT—epilepsy syndrome	1.8e-05	0.000177	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL3—epilepsy syndrome	1.79e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL2—epilepsy syndrome	1.79e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HSPB1—epilepsy syndrome	1.79e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CRH—epilepsy syndrome	1.79e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—OXT—epilepsy syndrome	1.79e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR5—epilepsy syndrome	1.76e-05	0.000174	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.75e-05	0.000173	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.73e-05	0.000171	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL12—epilepsy syndrome	1.73e-05	0.000171	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—POMC—epilepsy syndrome	1.73e-05	0.000171	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.73e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.73e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.73e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.72e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JUNB—epilepsy syndrome	1.7e-05	0.000168	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CNR1—epilepsy syndrome	1.7e-05	0.000168	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLCB1—epilepsy syndrome	1.7e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.67e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TSC1—epilepsy syndrome	1.66e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTK2B—epilepsy syndrome	1.66e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR7—epilepsy syndrome	1.66e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.64e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGT—epilepsy syndrome	1.64e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR2—epilepsy syndrome	1.62e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NTRK2—epilepsy syndrome	1.62e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SST—epilepsy syndrome	1.62e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HBEGF—epilepsy syndrome	1.61e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.61e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.61e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DUSP6—epilepsy syndrome	1.6e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.58e-05	0.000156	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT3—epilepsy syndrome	1.58e-05	0.000156	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLAT—epilepsy syndrome	1.58e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—POMC—epilepsy syndrome	1.57e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NPY—epilepsy syndrome	1.57e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.57e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADAM10—epilepsy syndrome	1.55e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL2—epilepsy syndrome	1.54e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.52e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL12—epilepsy syndrome	1.52e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.52e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—POMC—epilepsy syndrome	1.52e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.51e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—OXT—epilepsy syndrome	1.51e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.51e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.51e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CRH—epilepsy syndrome	1.51e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.51e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.51e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JUNB—epilepsy syndrome	1.49e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CNR1—epilepsy syndrome	1.49e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.49e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLCB1—epilepsy syndrome	1.49e-05	0.000146	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—S100B—epilepsy syndrome	1.46e-05	0.000144	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.46e-05	0.000144	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR7—epilepsy syndrome	1.46e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SOCS3—epilepsy syndrome	1.45e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDC42—epilepsy syndrome	1.44e-05	0.000142	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HBEGF—epilepsy syndrome	1.41e-05	0.000139	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.41e-05	0.000139	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.4e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.4e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AVP—epilepsy syndrome	1.4e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT3—epilepsy syndrome	1.39e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—POMC—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.37e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SST—epilepsy syndrome	1.37e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.37e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADAM10—epilepsy syndrome	1.36e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.35e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL2—epilepsy syndrome	1.35e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.34e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.33e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HES1—epilepsy syndrome	1.32e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FYN—epilepsy syndrome	1.29e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.28e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.28e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.28e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—S100B—epilepsy syndrome	1.28e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—H2AFX—epilepsy syndrome	1.28e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.28e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MEF2C—epilepsy syndrome	1.28e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.27e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SOCS3—epilepsy syndrome	1.27e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDC42—epilepsy syndrome	1.27e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.26e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.26e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.26e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.24e-05	0.000122	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.23e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AVP—epilepsy syndrome	1.23e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NGF—epilepsy syndrome	1.22e-05	0.00012	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.19e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR5—epilepsy syndrome	1.19e-05	0.000117	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.17e-05	0.000115	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.17e-05	0.000115	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2A—epilepsy syndrome	1.16e-05	0.000115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HES1—epilepsy syndrome	1.16e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.15e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.14e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FYN—epilepsy syndrome	1.13e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—H2AFX—epilepsy syndrome	1.12e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	1.12e-05	0.00011	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	1.1e-05	0.000109	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	1.1e-05	0.000109	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.08e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	1.08e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	1.08e-05	0.000106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.07e-05	0.000106	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	1.07e-05	0.000106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.07e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	1.06e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	1.04e-05	0.000103	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	1.04e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	1.02e-05	0.0001	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	1.02e-05	0.0001	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	1.02e-05	0.0001	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	9.79e-06	9.65e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	9.69e-06	9.54e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	9.67e-06	9.53e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	9.52e-06	9.38e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	9.49e-06	9.35e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	9.48e-06	9.34e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	9.47e-06	9.33e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	9.29e-06	9.15e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	9.29e-06	9.15e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.16e-06	9.02e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	9.09e-06	8.95e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	9.05e-06	8.92e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	8.94e-06	8.81e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	8.9e-06	8.77e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	8.81e-06	8.67e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	8.62e-06	8.49e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	8.21e-06	8.09e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	8.19e-06	8.06e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	8.18e-06	8.05e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	8.14e-06	8.02e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	8.01e-06	7.89e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	7.97e-06	7.85e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	7.85e-06	7.73e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	7.62e-06	7.51e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	7.56e-06	7.44e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	7.53e-06	7.41e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	7.48e-06	7.36e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	7.2e-06	7.09e-05	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.94e-06	6.84e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	6.88e-06	6.78e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	6.88e-06	6.77e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	6.73e-06	6.63e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	6.68e-06	6.58e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	6.68e-06	6.58e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	6.56e-06	6.46e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	6.5e-06	6.4e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	6.3e-06	6.21e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	6.09e-06	6e-05	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.09e-06	5.99e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	6.03e-06	5.94e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	5.99e-06	5.9e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	5.86e-06	5.77e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	5.83e-06	5.75e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	5.7e-06	5.61e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	5.65e-06	5.57e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	5.54e-06	5.46e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	5.53e-06	5.44e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	5.25e-06	5.17e-05	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.14e-06	5.07e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	5.12e-06	5.04e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	5.1e-06	5.02e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	4.95e-06	4.88e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	4.82e-06	4.74e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.67e-06	4.6e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	4.44e-06	4.37e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	4.32e-06	4.26e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	3.72e-06	3.67e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	3.26e-06	3.22e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.76e-06	2.72e-05	CbGpPWpGaD
